Zaloguj się

Gotowe bibliografie tematyczne / Pharmacovigilance in dermatology

Spis treści

Artykuły w czasopismach
Rozprawy doktorskie
Części książek

Gotowa bibliografia na temat „Pharmacovigilance in dermatology”

Autor: Grafiati

Data publikacji: 2 czerwca 2025

Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Pharmacovigilance in dermatology”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Pharmacovigilance in dermatology"

1

Lebwohl, Mark, Andrea Murina, George Han, and Abby Jacobson. "Brodalumab: 4-Year US Pharmacovigilance Report." SKIN The Journal of Cutaneous Medicine 7, no. 2 (2023): s132. http://dx.doi.org/10.25251/skin.7.supp.132.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Garcia‐Doval, I., E. Segovia, H. Hunter, J. Frew, and L. Naldi. "The value of case reports in pharmacovigilance." British Journal of Dermatology 183, no. 5 (2020): 795–96. http://dx.doi.org/10.1111/bjd.19504.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Schmutz, J. L. "Alitrétinoïne (Toctino®) : données récentes de pharmacovigilance." Annales de Dermatologie et de Vénéréologie 147, no. 4 (2020): 329–30. http://dx.doi.org/10.1016/j.annder.2020.01.002.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Bettuzzi, Thomas, Aaron Drucker, Delphine Staumont-Sallé, Kevin Bihan, Bénédicte Lebrun-Vignes, and Emilie Sbidian. "34927 Adverse events associated with dupilumab in the WHO pharmacovigilance." Journal of the American Academy of Dermatology 87, no. 3 (2022): AB136. http://dx.doi.org/10.1016/j.jaad.2022.06.578.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Khopkar, Uday. "Reporting of drug eruptions: The national pharmacovigilance program." Indian Journal of Dermatology, Venereology and Leprology 71, no. 1 (2005): 1. http://dx.doi.org/10.4103/0378-6323.13776.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

International, Journal of Medical Science and Advanced Clinical Research (IJMACR). "Evaluation of Adverse Drug Reactions in Outpatients and Inpatients in Department of Dermatology at Tertiary Care Hospital." International Journal of Medical Science and Advanced Clinical Research (IJMACR) 8, no. 2 (2025): 20–28. https://doi.org/10.5281/zenodo.15239868.

Pełny tekst źródła

Streszczenie:

<strong>Abstract</strong> <strong>Objective: </strong>The study aims to evaluate the clinical spectrum, morphology, and causative drugs responsible for CADRs in inpatients and outpatients attending the dermatology department of a tertiary care center. It also emphasizes the necessity of an effective pharmacovigilance system to improve drug safety and minimize CADR-related morbidity and mortality. <strong>Methods</strong>: A cross-sectional observational study was conducted at a tertiary care center in Jamnagar, Gujarat, from January 2023 to June 2024. A total of 150 patients presenting with CA

Style APA, Harvard, Vancouver, ISO itp.

7

Paul, C. "Science, marketing et pharmacovigilance : l’exemple des inhibiteurs topiques de la calcineurine." Annales de Dermatologie et de Vénéréologie 134, no. 11 (2007): 817–21. http://dx.doi.org/10.1016/s0151-9638(07)92823-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

CASTRO, Clarisse F., Cesar A. TEIXEIRA, Nurimar C. FERNANDES, and Guacira C. MATOS. "Severe cutaneous adverse reactions to drugs: a case series study." Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde 11, no. 3 (2020): 471. http://dx.doi.org/10.30968/rbfhss.2020.113.0471.

Pełny tekst źródła

Streszczenie:

Objective: to describe five cases of severe cutaneous adverse reactions to drugs (SCARD) that led to hospitalization and were investigated and diagnosed by the dermatology service of a university hospital. Methods: this is a descriptive observational study of the case series type in which were included patients aged 18 years old or older from both sexes, hospitalized between January 2015 and July 2019, in a university hospital in Rio de Janeiro, Brazil and whose reason for hospitalization was SCARD diagnosed by the dermatology service. For SCARD causality assessments, two internationally adopt

Style APA, Harvard, Vancouver, ISO itp.

9

Pelet del Toro, Natalia, Andrew Strunk, Jashin Wu, et al. "Topical Clindamycin For Acne Vulgaris: Pharmacovigilance Safety Review and Retrospective Analysis of Gastrointestinal Events." SKIN The Journal of Cutaneous Medicine 8, no. 1 (2024): s341. http://dx.doi.org/10.25251/skin.8.supp.341.

Pełny tekst źródła

Streszczenie:

Background: Clindamycin, a lincosamide antibiotic, was the 125th most prescribed medicine in the US in 2020. Topical formulations that combine clindamycin with benzoyl peroxide or a retinoid are commonly used for acne vulgaris (AV) treatment. While oral and topical clindamycin carry warnings/contraindications regarding the development of gastrointestinal (GI) adverse events (AEs), the real-world incidence of these AEs with topical clindamycin is unknown. The objective is to provide an overview of safety data for topical clindamycin when used for AV treatment. Methods: Safety data from pu

Style APA, Harvard, Vancouver, ISO itp.

10

Pelet del Toro, Natalia, Andrew Strunk, Jashin Wu, et al. "Topical Clindamycin For Acne Vulgaris: Pharmacovigilance Safety Review and Retrospective Analysis of Gastrointestinal Events." SKIN The Journal of Cutaneous Medicine 8, no. 1 (2024): s356. http://dx.doi.org/10.25251/skin.8.supp.356.

Pełny tekst źródła

Streszczenie:

Background: Clindamycin, a lincosamide antibiotic, was the 125th most prescribed medicine in the US in 2020. Topical formulations that combine clindamycin with benzoyl peroxide or a retinoid are commonly used for acne vulgaris (AV) treatment. While oral and topical clindamycin carry warnings/contraindications regarding the development of gastrointestinal (GI) adverse events (AEs), the real-world incidence of these AEs with topical clindamycin is unknown. The objective is to provide an overview of safety data for topical clindamycin when used for AV treatment. Methods: Safety data from pu

Style APA, Harvard, Vancouver, ISO itp.

Więcej źródeł

Rozprawy doktorskie na temat "Pharmacovigilance in dermatology"

1

Paultre-Béliveau, Solange. "Dermatovigilance hospitalière chez les enfants de 0 à 4 ans." Thèse, 2003. http://hdl.handle.net/1866/14167.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Części książek na temat "Pharmacovigilance in dermatology"

1

Kalb, Robert E. "Pharmacovigilance." In Biologic and Systemic Agents in Dermatology. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-66884-0_9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Kumar, Rishi, V. Kalaiselvan, and G. N. Singh. "Topical Corticosteroids: The Pharmacovigilance Perspective." In A Treatise on Topical Corticosteroids in Dermatology. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-4609-4_32.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Gelfand, Joel M., and Megan H. Noe. "Pharmacovigilance." In Comprehensive Dermatologic Drug Therapy. Elsevier, 2021. http://dx.doi.org/10.1016/b978-0-323-61211-1.00007-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Gelfand, Joel M., and Sinéad M. Langan. "Pharmacovigilance." In Comprehensive Dermatologic Drug Therapy. Elsevier, 2013. http://dx.doi.org/10.1016/b978-1-4377-2003-7.00006-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!